TY  - BOOK
ED  - United States.
TI  - Examining the actions of drug companies in raising prescription drug prices: hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, January 29, 2019
AV  - KF27 .O96 2019a
PY  - 2019///
CY  - Washington
PB  - U.S. Government Publishing Office
KW  - Prescription pricing
KW  - Government policy
KW  - United States
KW  - Pharmaceutical industry
KW  - Drugs
KW  - Cost control
KW  - Prices
KW  - Health aspects
KW  - Legislative hearings
KW  - lcgft
N1  - "Serial no. 116-01."; CRDP Program record
UR  - https://purl.fdlp.gov/GPO/gpo122460
UR  - https://purl.fdlp.gov/GPO/gpo122497
ER  -